A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy
Contact Person
Status
Pending
Disease Site
Endometrial
Lead Cooperative Group
Participating Groups
BGOG
CEEGOG
NSGO-CTU
AGO-AUST
ISGO
MaNGO
DGOG
CTI
GEICO
NCRI
GINECO
SAKK